Matthew Fishbaugher
Overview
Explore the profile of Matthew Fishbaugher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
640
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Flannery E, Kangwanrangsan N, Chuenchob V, Roobsoong W, Fishbaugher M, Zhou K, et al.
Mol Ther Methods Clin Dev
. 2022 Sep;
26:427-440.
PMID: 36092359
is a malaria-causing pathogen that establishes a dormant form in the liver (the hypnozoite), which can activate weeks, months, or years after the primary infection to cause a relapse, characterized...
2.
Healy S, Murphy S, Hume J, Shelton L, Kuntz S, Van Voorhis W, et al.
Clin Infect Dis
. 2019 Oct;
71(6):1481-1490.
PMID: 31621832
Background: Chemoprophylaxis vaccination with sporozoites (CVac) with chloroquine induces protection against a homologous Plasmodium falciparum sporozoite (PfSPZ) challenge, but whether blood-stage parasite exposure is required for protection remains unclear. Chloroquine...
3.
Foquet L, Schafer C, Minkah N, Alanine D, Flannery E, Steel R, et al.
Front Immunol
. 2018 Mar;
9:524.
PMID: 29593746
The invention of liver-humanized mouse models has made it possible to directly study the preerythrocytic stages of . In contrast, the current models to directly study blood stage infection are...
4.
Zenklusen I, Jongo S, Abdulla S, Ramadhani K, Sim B, Cardamone H, et al.
J Infect Dis
. 2018 Feb;
217(10):1569-1578.
PMID: 29438525
Background: The assessment of antibody responses after immunization with radiation-attenuated, aseptic, purified, cryopreserved Plasmodium falciparum sporozoites (Sanaria PfSPZ Vaccine) has focused on IgG isotype antibodies. Here, we aimed to investigate...
5.
Flannery E, Foquet L, Chuenchob V, Fishbaugher M, Billman Z, Navarro M, et al.
JCI Insight
. 2018 Jan;
3(1).
PMID: 29321371
Malaria eradication necessitates new tools to fight the evolving and complex Plasmodium pathogens. These tools include prophylactic drugs that eliminate Plasmodium liver stages and consequently prevent clinical disease, decrease transmission,...
6.
Sack B, Mikolajczak S, Fishbaugher M, Vaughan A, Flannery E, Nguyen T, et al.
NPJ Vaccines
. 2017 Dec;
2:27.
PMID: 29263882
A malaria vaccine that prevents infection will be an important new tool in continued efforts of malaria elimination, and such vaccines are under intense development for the major human malaria...
7.
Murphy S, Duke E, Shipman K, Jensen R, Fong Y, Ferguson S, et al.
J Infect Dis
. 2017 Dec;
217(5):693-702.
PMID: 29216395
Background: DSM265 is a selective inhibitor of Plasmodium dihydroorotate dehydrogenase that fully protected against controlled human malarial infection (CHMI) by direct venous inoculation of Plasmodium falciparum sporozoites when administered 1...
8.
Ortega C, Frando A, Webb-Robertson B, Anderson L, Fleck N, Flannery E, et al.
Mol Cell Proteomics
. 2017 Oct;
17(1):111-120.
PMID: 29079720
Effective malaria control and elimination in hyperendemic areas of the world will require treatment of the () blood stage that causes disease as well as the gametocyte stage that is...
9.
Hanron A, Billman Z, Seilie A, Olsen T, Fishbaugher M, Chang M, et al.
Malar J
. 2017 May;
16(1):208.
PMID: 28526032
Background: Plasmodium gametocytes are sexual stages transmitted to female Anopheles mosquitoes. While Plasmodium parasites can be differentiated microscopically on Giemsa-stained blood smears, molecular methods are increasingly used because of their...
10.
Ishizuka A, Lyke K, DeZure A, Berry A, Richie T, Mendoza F, et al.
Nat Med
. 2016 Jun;
22(6):692.
PMID: 27270781
No abstract available.